Authors: I. Viktorova B., V. Zimina N., S. Degtyareva Yu., A. Kravtchenko V., И. Викторова Б., В. Зимина Н., С. Дегтярева Ю., А. Кравченко В.

Superior Title: Journal Infectology; Том 12, № 4 (2020); 5-18 ; Журнал инфектологии; Том 12, № 4 (2020); 5-18 ; 2072-6732 ; 10.22625/2072-6732-2020-12-4

Subject Terms: HIV-infection, opportunistic infections, tuberculosis, pneumocystis pneumonia, lymphoma, ВИЧ-инфекция, вторичные инфекции, туберкулез, пневмоцистная пневмония, лимфома

File Description: application/pdf

Relation: https://journal.niidi.ru/jofin/article/view/1096/824; Global AIDS monitoring 2018: indicators for monitoring the 2016 United Nations Political Declaration on HIV and AIDS. Geneva: UNAIDS; 2018 [Internet]. 2018. [Cited 23.08.2019] Available from: http://www.unaids.org/sites/default/files/media_asset/global-aids-monitoring_en.pdf; Шахгильдян, В.И. Структура вторичных заболеваний и современные походы к их лабораторной диагностике у больных ВИЧ-инфекцией / В.И. Шахгильдян [и др.] // Эпидемиология и инфекционные болезни. – 2015. – № 1. – С. 24–30.; Benito N, Rañó A, Moreno A, González J, Luna M, Agustí C, et al. Pulmonary Infiltrates in HIV-Infected Patients in the Highly Active Antiretroviral Therapy Era in Spain. JAIDS J Acquir Immune Defic Syndr [Internet]. 2001;27:35–43. [Cited 23.08.2019] Available from: https://journals.lww.com/jaids/Fulltext/2001/05010/Pulmonary_Infiltrates_in_HIV_Infected_Patients_in.6.aspx; Kohli R, Lo Y, Homel P, Flanigan TP, Gardner LI, Howard AA, et al. Bacterial Pneumonia, HIV Therapy, and Disease Progression among HIV-Infected Women in the HIV Epidemiologic Research (HER) Study. Clin Infect Dis. 2006;43(1):90–8.; Sullivan JH, Moore RD, Keruly JC, Chaisson RE. Effect of Antiretroviral Therapy on the Incidence of Bacterial Pneumonia in Patients with Advanced HIV Infection. 2000;162:64–7.; Cillóniz C, García-Vidal C, Moreno A, Miro JM, Torres A. Community-acquired bacterial pneumonia in adult HIV-infected patients. Expert Rev Anti Infect Ther [Internet]. 2018 Jul 3;16(7):579–88. [Cited 23.08.2019] Available from: https://doi.org/10.1080/14787210.2018.1495560; Gordin FM, Roediger MP, Girard PM, Lundgren JD, Miro JM, Palfreeman A, et al. Pneumonia in HIV-infected persons: Increased risk with cigarette smoking and treatment interruption. Am J Respir Crit Care Med. 2008;178(6):630–6.; Mane A, Gujar P, Gaikwad S, Bembalkar S, Gaikwad S, Dhamgaye T, et al. Aetiological spectrum of severe communityacquired pneumonia in HIV-positive patients from Pune, India. Indian J Med Res [Internet]. 2018 Feb;147(2):202–6. [Cited 04.07.2019] Available from: https://www.ncbi.nlm.nih.gov/pubmed/29806610; Saindou M, Chidiac C, Miailhes P, Voirin N, Baratin D, Amiri M, et al. Pneumococcal pneumonia in HIV-infected patients by antiretroviral therapy periods. HIV Med. 2008 Apr;9(4):203–7.; Cordero E, Pachon J, Rivero A, Giron JA, Gomez-Mateos J, Merino MD, et al. Haemophilus influenzae Pneumonia in Human Immunodeficiency Virus-Infected Patients. Clin Infect Dis. 2000;30(3):461–5.; Park DR, Sherbin VL, Goodman MS, Pacifico AD, Rubenfeld GD, Polissar NL, et al. The Etiology of Community Acquired Pneumonia at an Urban Public Hospital: Influence of Human Immunodeficiency Virus Infection and Initial Severity of Illness. J Infect Dis. 2001;184(3):268–77. doi:10.1086/322040; Head BM, Trajtman A, Rueda Z V, Vélez L, Keynan Y. Atypical bacterial pneumonia in the HIV-infected population. Pneumonia. 2017;9(12):1–7.; Sinclair A, Xie X, Teltscher M. Systematic Review and Meta-Analysis of a Urine-Based Pneumococcal Antigen Test for Diagnosis of Community-Acquired Pneumonia Caused by Streptococcus pneumoniae. J Clin Microbiol. 2013;51(7):2303–10.; Gatserelia L, Sharvadze L, Karchava M, Babridze N, Tsetvadze T, Dvali N, et al. Procalcitonin as a marker of bacterial sepsis in immunocompromised patients. Retrovirology [Internet]. 2012;9(Suppl 1):P90. [Cited 04.07.2019] Available from: http://www.retrovirology.com/content/9/S1/P90; Mikuła T, Suchacz M, Stańczak W, Kozłowska J, Wiercińska-Drapało A. Procalcitonin as a Biomarker of the Early Stage of Bacterial Infections in HIV/AIDS Patients. Eur J Inflamm. 2014 May 1;12(2):305–13. doi: org/10.1177/1721727X1401200210; Schleicher GK, Herbert V, Brink A, Martin S, Maraj R, Galpin JS, et al. Procalcitonin and C-reactive protein levels in HIV-positive subjects with tuberculosis and pneumonia. Eur Respir J. 2005 Apr;25(4):688–92.; Mendelson F, Griesel R, Tiffin N, Rangaka M, Boulle A, Mendelson M, et al. C-reactive protein and procalcitonin to discriminate between tuberculosis, Pneumocystis jirovecii pneumonia, and bacterial pneumonia in HIV-infected inpatients meeting WHO criteria for seriously ill: a prospective cohort study. BMC Infect Dis. 2018 Aug;18(1):399.; Swaminathan S, Padmapriyadarsini C, Narendran G. HIV-associated tuberculosis: clinical update. Clin Infect Dis. 2010 May;50(10):1377–86.; Зимина, В.Н. Эпидемиология, течение и особенности лечения туберкулеза у больных ВИЧ-инфекцией / В.Н. Зимина, А.В. Кравченко, И.Б. Викторова // Медицина в Кузбассе. – 2011. – №. 3. – С. 6–13.; Викторова, И.Б. Бактериовыделение у пациентов с ВИЧ-инфекцией и туберкулезом / И.Б. Викторова [и др.] // Эпидемиология и инфекционные болезни. Актуальные вопросы. – 2018. – №3. – С. 35–40.; Morris A, Sciurba FC, Lebedeva IP, Githaiga A, Elliott WM, Hogg JC, et al. Association of chronic obstructive pulmonary disease severity and Pneumocystis colonization. Am J Respir Crit Care Med. 2004;170(4):408–13.; Schmidt JJ, Lueck C, Ziesing S, Stoll M, Haller H, Gottlieb J, et al. Clinical course, treatment and outcome of Pneumocystis pneumonia in immunocompromised adults: a retrospective analysis over 17 years. Crit Care. 2018;22(1):307.; Ермак, Т.Н. Генерализованный пневмоцистоз с поражением кожи при ВИЧ-инфекции / Т.Р. Ермак, М.Г. Ласеева // Инфекционные болезни. – 2017. – № 4. – С. 91–94.; Kanne JP, Yandow DR, Meyer CA. Pneumocystis jiroveci pneumonia: High-resolution CT findings in patients with and without HIV infection. Am J Roentgenol. 2012;198(6):555–61.; Morris A, Crothers K, Beck JM, Huang L. An Official ATS Workshop Report: Emerging Issues and Current Controversies in HIV-Associated Pulmonary Diseases. Proc Am Thorac Soc. 2011;8(1):17–26.; Skelly MJ, Holzman RS, Merali S. S-Adenosylmethionine Levels in the Diagnosis of Pneumocystis carinii Pneumonia in Patients with HIV Infection. Clin Infect Dis. 2008;46(3):467–71.; Li H, Huang H, He H. Successful treatment of severe Pneumocystis pneumonia in an immunosuppressed patient using caspofungin combined with clindamycin: A case report and literature review. BMC Pulm Med. 2016;16(1):1–6. doi: org/10.1186/s12890-016-0307-0; Nickel P, Schurmann M, Albrecht H, Schindler R, Budde K, Westhoff T, et al. Clindamycin-primaquine for pneumocystis jiroveci pneumonia in renal transplant patients. Infection. 2014 Dec;42(6):981–9.; Morris SR, Zhao M, Smith DM, Vargas M V., Little SJ, Gianella S. Longitudinal viral dynamics in semen during early HIV infection. Clin Infect Dis. 2017;64(4):428–34.; Udeze A, Odebisi-Omokanye M, Ajileye T. Cytomegalovirus infection among Human Immunodeficiency Virus (HIV) infected individuals on highly active anti-retroviral therapy in North-Central Nigeria. Afr Health Sci. 2018 Dec;18(4):1057– 65.; Шахгильдян, В.И. Клинико-лабораторная характеристика, патоморфологические особенности, диагностика и лечение цитомегаловирусной пневмонии / В.И. Шахгильдян, О.А. Тишкевич, О.Ю. Шипулина // Инфекционные болезни. – 2004. – Т. 2, № 1. – С. 73–80.; Hooks B, Abboud R. CMV Pneumonitis: A Rare and Infrequent Coinfection of Pneumonia in AIDS. Chest [Internet]. 2017 Oct 1;152(4):A170. [Cited 23.08.2019] Available from: https://doi.org/10.1016/j.chest.2017.08.201; Perez C, Garcia P, Calvo M, Labarca J, Bustos M, Beroiza T, et al. Etiology of pneumonia in chilean HIV-infected adult patients. Rev Chilena Infectol. 2011 Aug;28(4):343–8.; Guidelines for the Prevention and Treatment of Opportunistic Infections Among HIV-Exposed and HIV-Infected Children. [Internet]. 2019 [Cited 31.07.2019] Available from: https://aidsinfo.nih.gov/contentfiles/lvguidelines/oi_guidelines_pediatrics.pdf; Шахгильдян, В.И. Структура вторичных заболеваний и современные походы к их лабораторной диагностике у больных ВИЧ-инфекцией / В.И. Шахгильдян [и др.] // Эпидемиология и инфекционные болезни. Актуальные вопросы. – 2015. – № 1.- С. 24–30.; EL Fane M, Sodqi M, EL Rherbi A, Chakib A, Oulad Lahsen A, Marih L MEFK. Antimicrobial Agents Cytomegalovirus Disease in Patient with HIV Infection. J Antimicro. 2016;(1):108.; Soderberg-Naucler C. Treatment of cytomegalovirus infections beyond acute disease to improve human health. Expert Rev Anti Infect Ther. 2014 Feb;12(2):211–22.; Park BJ, Wannemuehler KA, Marston BJ, Govender N, Pappas PG, Chiller TM. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/ AIDS. AIDS. 2009 Feb;23(4):525–30.; Rajasingham R, Smith RM, Park BJ, Jarvis JN, Govender NP, Chiller TM, et al. Global burden of disease of HIV-associated cryptococcal meningitis: an updated analysis. Lancet Infect Dis. 2017 Aug;17(8):873–81.; World Health Organization Rapid Advice: Diagnosis, Prevention and Management of Cryptococcal Disease in HIVInfected Adults, Adolescents and Children: December 2011 [Internet]. 2011 [Cited 20.08.2017] Available from: https://apps.who.int/iris/bitstream/handle/10665/44786/9789241502979_eng.pdf?sequence=1; Meyohas MC, Roux P, Bollens D, Chouaid C, Rozenbaum W, Meynard JL, et al. Pulmonary cryptococcosis: localized and disseminated infections in 27 patients with AIDS. Clin Infect Dis. 1995 Sep;21(3):628–33.; Antinori S. New Insights into HIV/AIDS-Associated Cryptococcosis. ISRN AIDS. 2013 Feb;2013:471363.; Colombo AL, Tobon A, Restrepo A, Queiroz-Telles F, Nucci M. Epidemiology of endemic systemic fungal infections in Latin America. Med Mycol. 2011 Nov;49(8):785–98.; Ashbee HR, Evans EG V, Viviani MA, Dupont B, Chryssanthou E, Surmont I, et al. Histoplasmosis in Europe: report on an epidemiological survey from the European Confederation of Medical Mycology Working Group. Med Mycol. 2008 Feb;46(1):57–65.; Adenis AA, Aznar C, Couppie P. Histoplasmosis in HIVInfected Patients: A Review of New Developments and Remaining Gaps. Vol. 1, Current tropical medicine reports. Switzerland; 2014. p. 119–28.; Hage CA, Ribes JA, Wengenack NL, Baddour LM, Assi M, McKinsey DS, et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis. 2011 Sep;53(5):448– 54.; Panel on Antiretroviral Guidelines for Adults and Adolescents. Guidelines for the Use of Antiretroviral Agents in Adults and Adolescents with HIV. Department of Health and Human Services. [Internet]. 2019 p. 423. [Cited 15.07.2019]. Available from: http://aidsinfo.nih.gov/contentfiles/lvguidelines/adult_oi.pdf. Accessed 5/24/2019.; Maheshwari M, Kaur R, Chadha S. Candida Species Prevalence Profile in HIV Seropositive Patients from a Major Tertiary Care Hospital in New Delhi, India. J Pathog. 2016;2016:6204804.; Roohani AH, Fatima N, Shameem M, Khan HM, Khan PA, Akhtar A. Comparing the profile of respiratory fungal pathogens amongst immunocompetent and immunocompromised hosts, their susceptibility pattern and correlation of various opportunistic respiratory fungal infections and their progression in relation to the CD4+T-c. Indian J Med Microbiol. 2018;36(3):408–15.; Kaur R, Mehra B, Dhakad MS, Goyal R, Bhalla P, Dewan R. Fungal Opportunistic Pneumonias in HIV/AIDS Patients: An Indian Tertiary Care Experience. J Clin Diagn Res. 2017 Feb;11(2):DC14–9.; Ito Y, Hirai T, Maekawa K, Fujita K, Imai S, Tatsumi S, et al. Predictors of 5-year mortality in pulmonary Mycobacterium avium-intracellulare complex disease. Int J Tuberc Lung Dis. 2012;16(3):408–14.; Griffith DE, Aksamit T, Brown-Elliott BA, Catanzaro A, Daley C, Gordin F, et al. An official ATS/IDSA statement: Diagnosis, treatment, and prevention of nontuberculous mycobacterial diseases. Am J Respir Crit Care Med. 2007;175(4):367–416. 53. Пантелеев, А.М. Дифференциальная диагностика туберкулеза и микобактериоза у больных ВИЧ-инфекцией / А.М. Пантелеев [и др.] // Туберкулез и болезни легких. – 2017. – № 95, Т.10. – С. 47–52.; Зимина, В.Н. Микобактериозы: современное состояние проблемы / В.Н. Зимина [и др.] // Клиническая микробиология и антимикробная терапия. – 2017. – Т. 19, № 4. – С. 276–282.; Yangco BG, Buchacz K, Baker R, Palella FJ, Armon C, Brooks JT. Is primary mycobacterium avium complex prophylaxis necessary in patients with CD4; https://journal.niidi.ru/jofin/article/view/1096

Availability: https://doi.org/10.22625/2072-6732-2020-12-4-5-18
https://doi.org/10.22625/2072-6732-2020-12-4
https://doi.org/10.1080/14787210.2018.1495560
https://doi.org/10.1086/322040
https://doi.org/10.1177/1721727X1401200210
https://doi.org/10.1186/s12890-016-0307-0
https://doi.org/10.1016/j.chest.2017.08.201
https://journal.niidi.ru/jofin/article/view/1096